ComfortDelGro Corporation Limited (CDGLY)
USD 22.2
(0.0%)
USD 22.2
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 465.9 Million | 602.3 Million | 660.9 Million | 483.7 Million | 609.9 Million | 668.8 Million |
| Net Income | 180.5 Million | 272.7 Million | 204.9 Million | 117.2 Million | 406.6 Million | 439.3 Million |
| Depreciation & Amortization | 364.2 Million | 357.2 Million | 401.6 Million | 416.6 Million | 453 Million | 394.3 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.8 Million | 1.1 Million | 700 Thousand | 700 Thousand | 400 Thousand | - |
| Change in working capital | -125.5 Million | 75.3 Million | 94.7 Million | -10.2 Million | -120.5 Million | -53.2 Million |
| Other non-cash items | 46.7 Million | -102.9 Million | -40.3 Million | -39.9 Million | -129.2 Million | -111.6 Million |
| Investing Cash Flow | -360.9 Million | -251 Million | -203.8 Million | -109.7 Million | -366.6 Million | -637.9 Million |
| Investments in PPE | -378.5 Million | -304.6 Million | -230.1 Million | -199.8 Million | -506.7 Million | -368.2 Million |
| Acquisitions | 35.09 Million | -37.8 Million | -14.2 Million | -12 Million | -28.3 Million | -418.8 Million |
| Investment purchases | -17.5 Million | -2.1 Million | -2.2 Million | - | -3.1 Million | 15.4 Million |
| Sales/Maturities of investments | - | 2.2 Million | 1.9 Million | - | - | 10.4 Million |
| Other Investing Activities | 1.00 | 91.3 Million | 40.8 Million | 102.1 Million | 171.5 Million | 123.3 Million |
| Financing Cash Flow | -210.5 Million | -274.7 Million | -287.2 Million | -241.2 Million | -229.7 Million | -29 Million |
| Debt repayment | -47.8 Million | -2.51 Billion | -2.26 Billion | -2.11 Billion | -1.27 Billion | -215.5 Million |
| Dividends payments | -154.2 Million | -137.8 Million | -76.5 Million | -114.6 Million | -230.7 Million | -225.1 Million |
| Common Stock Repurchased | -1.4 Million | -1.7 Million | -700 Thousand | -400 Thousand | 1.21 Billion | - |
| Common Stock Issuance | -45 Million | - | 800 Thousand | 1.1 Million | 1.3 Million | 3.9 Million |
| Other Financing Activities | 37.9 Million | 2.38 Billion | 2.05 Billion | 1.98 Billion | 55 Million | -19.4 Million |
| Accounts receivables | -50.8 Million | 26 Million | 20.2 Million | -500 Thousand | -76 Million | -3.3 Million |
| Accounts payables | -23.8 Million | 76 Million | 93.1 Million | 1.6 Million | -28.2 Million | -5 Million |
| Inventory | -29 Million | -14.9 Million | 4.1 Million | 1.2 Million | -11.7 Million | -23.9 Million |
| Other working capital | -21.9 Million | -11.8 Million | -22.7 Million | -12.5 Million | -4.6 Million | -29.3 Million |
| Cash at beginning of period | 143.9 Million | 919.1 Million | 742.8 Million | 594.2 Million | 586.1 Million | 596.2 Million |
| Cash at end of period | 856.9 Million | 967 Million | 919.1 Million | 742.8 Million | 594.2 Million | 586.1 Million |
| Capital Expenditure | -378.5 Million | -304.6 Million | -230.1 Million | -199.8 Million | -506.7 Million | -368.2 Million |
| Effect of forex changes on cash | -4.6 Million | -28.7 Million | 6.4 Million | 15.8 Million | -5.5 Million | -12 Million |
| Net cash flow / Change in cash | 713 Million | 47.9 Million | 176.3 Million | 148.6 Million | 8.1 Million | -10.1 Million |
| Free Cash Flow | 87.4 Million | 297.7 Million | 430.8 Million | 283.9 Million | 103.2 Million | 300.6 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 47.65 Million | 47.65 Million | 180.5 Million | 51 Million | 51 Million | 39.25 Million |
| Depreciation & Amortization | 88.35 Million | 88.35 Million | 364.2 Million | 91.4 Million | 91.4 Million | 89.8 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 1.8 Million | 900 Thousand | 900 Thousand | - |
| Change in working capital | 20.35 Million | 20.35 Million | -125.5 Million | -52.1 Million | -52.1 Million | 1.25 Million |
| Other non-cash items | -11.55 Million | -11.55 Million | 46.7 Million | 27.15 Million | 27.15 Million | -24.1 Million |
| Investing Cash Flow | -212 Million | -212 Million | -360.9 Million | -83.85 Million | -83.85 Million | -81.4 Million |
| Investments in PPE | -106.5 Million | -106.5 Million | -378.5 Million | -101.4 Million | -101.4 Million | -82.35 Million |
| Acquisitions | -116.9 Million | -116.9 Million | 35.09 Million | 250 Thousand | 250 Thousand | -6.15 Million |
| Investment purchases | -900 Thousand | - | -17.5 Million | -6.6 Million | - | -10.9 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 11.4 Million | 11.4 Million | 1.00 | 17.3 Million | 17.3 Million | 7.1 Million |
| Financing Cash Flow | 79.2 Million | 79.2 Million | -210.5 Million | -44.15 Million | -44.15 Million | -67.9 Million |
| Debt repayment | -294.4 Million | - | -47.8 Million | -33 Million | - | -14.8 Million |
| Dividends payments | -40.75 Million | -40.75 Million | -154.2 Million | -31.4 Million | -31.4 Million | -45.7 Million |
| Common Stock Repurchased | -100 Thousand | -100 Thousand | -1.4 Million | - | - | -700 Thousand |
| Common Stock Issuance | - | - | -45 Million | - | - | -26.1 Million |
| Other Financing Activities | 120.05 Million | 120.05 Million | 37.9 Million | -12.75 Million | -12.75 Million | -21.5 Million |
| Accounts receivables | 29.5 Million | 29.5 Million | -50.8 Million | -23.05 Million | -23.05 Million | -2.25 Million |
| Accounts payables | -44.5 Million | - | -23.8 Million | 25.2 Million | - | -49 Million |
| Inventory | -8.19 Million | -8.19 Million | -29 Million | -7 Million | -7 Million | -7.5 Million |
| Other working capital | -950 Thousand | -950 Thousand | -21.9 Million | -22.05 Million | -22.05 Million | 11 Million |
| Cash at beginning of period | 188.3 Million | - | 143.9 Million | 877 Million | - | 143.9 Million |
| Cash at end of period | 883.7 Million | 13.4 Million | 856.9 Million | 188.3 Million | -10.05 Million | 877 Million |
| Capital Expenditure | -106.5 Million | -106.5 Million | -378.5 Million | -101.4 Million | -101.4 Million | -82.35 Million |
| Effect of forex changes on cash | 1.4 Million | 1.4 Million | -4.6 Million | -400 Thousand | -400 Thousand | -1.9 Million |
| Net cash flow / Change in cash | 695.4 Million | 13.4 Million | 713 Million | -688.7 Million | -10.05 Million | 733.1 Million |
| Free Cash Flow | 38.3 Million | 38.3 Million | 87.4 Million | 16.95 Million | 16.95 Million | 23.85 Million |
MDTR
RITM-PA
138A
8960
ORCHPHARMA
SKHCF